Ferring pulls the plug on drug hope just before phase 3
Ferring has scrapped a drug against septic shock that was developed through the company's Danish research center, which was about to begin phase 3 studies. That is how the industry is, says Ferring's Vice President in Denmark, who is now looking at drugs for fertility and pregnancy.
Swiss pharmaceutical company Ferring has scrapped a drug candidate in the late stages of development. The company's Danish research center was in charge of the drug candidate.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
